BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson RI, Lopez MF, Griffin WC, Haun HL, Bloodgood DW, Pati D, Boyt KM, Kash TL, Becker HC. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice. Neuropsychopharmacology 2019;44:1084-92. [PMID: 30555162 DOI: 10.1038/s41386-018-0294-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Placzek MS. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography. Handb Exp Pharmacol 2022;271:547-77. [PMID: 34363128 DOI: 10.1007/164_2021_498] [Reference Citation Analysis]
2 Ilari D, Maskri S, Schepmann D, Köhler J, Daniliuc CG, Koch O, Wünsch B. Diastereoselective synthesis of conformationally restricted KOR agonists. Org Biomol Chem 2021;19:4082-99. [PMID: 33978027 DOI: 10.1039/d1ob00398d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gantait AM, Bataineh YA, Surchi HS, Gantait A, Rani GT, Paul P, Kokaz SF, Al-jaidi BA, Kumar P, Karan S, Singha T. Neuropeptides and Neurotransmission. In: Kumar P, Deb PK, editors. Frontiers in Pharmacology of Neurotransmitters. Singapore: Springer; 2020. pp. 553-77. [DOI: 10.1007/978-981-15-3556-7_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bloodgood DW, Hardaway JA, Stanhope CM, Pati D, Pina MM, Neira S, Desai S, Boyt KM, Palmiter RD, Kash TL. Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake. Mol Psychiatry 2020. [PMID: 32099099 DOI: 10.1038/s41380-020-0690-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
5 Estave PM, Spodnick MB, Karkhanis AN. KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway. Handb Exp Pharmacol 2020. [PMID: 33301050 DOI: 10.1007/164_2020_421] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Smith LC, Kimbrough A. Leveraging Neural Networks in Preclinical Alcohol Research. Brain Sci 2020;10:E578. [PMID: 32825739 DOI: 10.3390/brainsci10090578] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Borrego MB, Chan AE, Ozburn AR. Regulation of alcohol drinking by ventral striatum and extended amygdala circuitry. Neuropharmacology 2022;:109074. [PMID: 35487273 DOI: 10.1016/j.neuropharm.2022.109074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Haun HL, Lebonville CL, Solomon MG, Griffin WC, Lopez MF, Becker HC. Dynorphin/Kappa Opioid Receptor Activity Within the Extended Amygdala Contributes to Stress-Enhanced Alcohol Drinking in Mice. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Haun HL, Griffin WC, Lopez MF, Becker HC. Kappa opioid receptors in the bed nucleus of the stria terminalis regulate binge-like alcohol consumption in male and female mice. Neuropharmacology 2020;167:107984. [PMID: 32023486 DOI: 10.1016/j.neuropharm.2020.107984] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Koob GF. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Pharmacol Rev 2021;73:163-201. [PMID: 33318153 DOI: 10.1124/pharmrev.120.000083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
11 Melkumyan M, Silberman Y. Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry. Front Mol Neurosci 2022;15:888345. [DOI: 10.3389/fnmol.2022.888345] [Reference Citation Analysis]
12 Nosova O, Bazov I, Karpyak V, Hallberg M, Bakalkin G. Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain. Molecules 2021;26:3458. [PMID: 34200173 DOI: 10.3390/molecules26113458] [Reference Citation Analysis]
13 Baird MA, Hsu TY, Wang R, Juarez B, Zweifel LS. κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety. eNeuro 2021;8:ENEURO. [PMID: 33323398 DOI: 10.1523/ENEURO.0370-20.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 King CE, Griffin WC, Lopez MF, Becker HC. Activation of hypothalamic oxytocin neurons reduces binge-like alcohol drinking through signaling at central oxytocin receptors. Neuropsychopharmacology 2021;46:1950-7. [PMID: 34127796 DOI: 10.1038/s41386-021-01046-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Egervari G, Siciliano CA, Whiteley EL, Ron D. Alcohol and the brain: from genes to circuits. Trends Neurosci 2021;44:1004-15. [PMID: 34702580 DOI: 10.1016/j.tins.2021.09.006] [Reference Citation Analysis]
16 Brunori G, Weger M, Schoch J, Targowska-Duda K, Barnes M, Borruto AM, Rorick-Kehn LM, Zaveri NT, Pintar JE, Ciccocioppo R, Toll L, Cippitelli A. NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice. Alcohol Clin Exp Res 2019;43:2167-78. [PMID: 31386211 DOI: 10.1111/acer.14165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Song J, Patel RV, Sharif M, Ashokan A, Michaelides M. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders. Mol Ther 2021:S1525-0016(21)00636-5. [PMID: 34861415 DOI: 10.1016/j.ymthe.2021.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Walker LC. A balancing act: the role of pro- and anti-stress peptides within the central amygdala in anxiety and alcohol use disorders. J Neurochem 2021;157:1615-43. [PMID: 33450069 DOI: 10.1111/jnc.15301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Torruella-Suárez ML, Vandenberg JR, Cogan ES, Tipton GJ, Teklezghi A, Dange K, Patel GK, McHenry JA, Hardaway JA, Kantak PA, Crowley NA, DiBerto JF, Faccidomo SP, Hodge CW, Stuber GD, McElligott ZA. Manipulations of Central Amygdala Neurotensin Neurons Alter the Consumption of Ethanol and Sweet Fluids in Mice. J Neurosci 2020;40:632-47. [PMID: 31744862 DOI: 10.1523/JNEUROSCI.1466-19.2019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
20 Khom S, Nguyen JD, Vandewater SA, Grant Y, Roberto M, Taffe MA. Self-Administration of Entactogen Psychostimulants Dysregulates Gamma-Aminobutyric Acid (GABA) and Kappa Opioid Receptor Signaling in the Central Nucleus of the Amygdala of Female Wistar Rats. Front Behav Neurosci 2021;15:780500. [PMID: 34975428 DOI: 10.3389/fnbeh.2021.780500] [Reference Citation Analysis]
21 Maiya R, Pomrenze MB, Tran T, Tiwari GR, Beckham A, Paul MT, Dayne Mayfield R, Messing RO. Differential regulation of alcohol consumption and reward by the transcriptional cofactor LMO4. Mol Psychiatry 2021;26:2175-86. [PMID: 32144357 DOI: 10.1038/s41380-020-0706-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lee GJ, Kim SA, Kim YJ, Oh SB. Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain. Brain Res 2021;1762:147445. [PMID: 33766518 DOI: 10.1016/j.brainres.2021.147445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Conway SM, Al-Hasani R. Comorbidities Are Complex: The Dynorphin/Kappa Opioid Receptor System in a Preclinical Model of Stress and Alcohol. Biol Psychiatry 2022;91:1000-2. [PMID: 35654556 DOI: 10.1016/j.biopsych.2022.04.005] [Reference Citation Analysis]
24 Tabbara RI, Rahbarnia A, Lê AD, Fletcher PJ. The pharmacological stressor yohimbine, but not U50,488, increases responding for conditioned reinforcers paired with ethanol or sucrose. Psychopharmacology (Berl) 2020;237:3689-702. [PMID: 32840668 DOI: 10.1007/s00213-020-05647-0] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Bauer MR, McVey MM, Germano DM, Zhang Y, Boehm SL 2nd. Intra-dorsolateral striatal AMPA receptor antagonism reduces binge-like alcohol drinking in male and female C57BL/6J mice. Behav Brain Res 2021;418:113631. [PMID: 34715146 DOI: 10.1016/j.bbr.2021.113631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nentwig TB, Obray JD, Vaughan DT, Chandler LJ. Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats. Sci Rep 2022;12:6595. [PMID: 35449195 DOI: 10.1038/s41598-022-10668-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Nall RW, Heinsbroek JA, Nentwig TB, Kalivas PW, Bobadilla AC. Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem 2021;157:1450-72. [PMID: 33420731 DOI: 10.1111/jnc.15297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Karkhanis AN, Al-Hasani R. Dynorphin and its role in alcohol use disorder. Brain Res 2020;1735:146742. [PMID: 32114059 DOI: 10.1016/j.brainres.2020.146742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]